Metabolism of tentoxin by hepatic cytochrome P-450 3A isozymes. 1997

M Delaforge, and F Andre, and M Jaouen, and H Dolgos, and H Benech, and J M Gomis, and J P Noel, and F Cavelier, and J Verducci, and J L Aubagnac, and B Liebermann
Université René Descartes, Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, CNRS URA 400, Paris, France. delaforg@bisance.citi2.fr

The interaction between rat and human liver cytochrome P-450 with tentoxin, a natural phytotoxic cyclotetrapeptide having chlorotic properties, was studied by difference ultraviolet visible spectroscopy. Tentoxin interacted with rat liver microsomes and the difference spectrum was characteristic of binding to a protein site close to the heme. The intensity of this spectrum was clearly dependent on the amounts of P-450 3A in the microsomes and was optimal in dexamethasone-treated rat microsomes. Tentoxin exhibited a high affinity for P-450 3A (Ks approximately 10 microM). Similar results were observed with human P-450 isozymes expressed in yeast. Only P-450 3A4 and 3A5 were able to give spectral interactions with tentoxin. Liver microsomes from rats pretreated with dexamethasone, a specific inducer of P-450 3A, were found to be particularly active for the oxidation of tentoxin, which occurs mainly on its Ala(Me) function leading to demethylation. Yeast-expressed P-450 3A also exhibited high activity to metabolize tentoxin. The metabolites were identified by their ultraviolet and mass spectra in fast atom bombardment and collision-activated dissociation modes. In addition to the major N-demethylated metabolite, other hydroxylated metabolites were formed. Preliminary analysis showed that as tentoxin, some metabolites were still efficient chloroplast ATPase inhibitors, while at least one of them exhibited even at low concentration stimulatory effects.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009183 Mycotoxins Toxic compounds produced by FUNGI. Fungal Toxins,Mycotoxin,Toxins, Fungal
D010089 Oxidoreductases, N-Demethylating N-Demethylase,N-Demethylases,Oxidoreductases, N Demethylating,Demethylating Oxidoreductases, N,N Demethylase,N Demethylases,N Demethylating Oxidoreductases,N-Demethylating Oxidoreductases
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.

Related Publications

M Delaforge, and F Andre, and M Jaouen, and H Dolgos, and H Benech, and J M Gomis, and J P Noel, and F Cavelier, and J Verducci, and J L Aubagnac, and B Liebermann
January 1984, IARC scientific publications,
M Delaforge, and F Andre, and M Jaouen, and H Dolgos, and H Benech, and J M Gomis, and J P Noel, and F Cavelier, and J Verducci, and J L Aubagnac, and B Liebermann
February 1986, Journal of chromatography,
M Delaforge, and F Andre, and M Jaouen, and H Dolgos, and H Benech, and J M Gomis, and J P Noel, and F Cavelier, and J Verducci, and J L Aubagnac, and B Liebermann
January 1989, Drug metabolism reviews,
M Delaforge, and F Andre, and M Jaouen, and H Dolgos, and H Benech, and J M Gomis, and J P Noel, and F Cavelier, and J Verducci, and J L Aubagnac, and B Liebermann
May 1999, The Journal of pharmacology and experimental therapeutics,
M Delaforge, and F Andre, and M Jaouen, and H Dolgos, and H Benech, and J M Gomis, and J P Noel, and F Cavelier, and J Verducci, and J L Aubagnac, and B Liebermann
July 1983, Biochemical and biophysical research communications,
M Delaforge, and F Andre, and M Jaouen, and H Dolgos, and H Benech, and J M Gomis, and J P Noel, and F Cavelier, and J Verducci, and J L Aubagnac, and B Liebermann
March 1985, Cancer research,
M Delaforge, and F Andre, and M Jaouen, and H Dolgos, and H Benech, and J M Gomis, and J P Noel, and F Cavelier, and J Verducci, and J L Aubagnac, and B Liebermann
March 1981, Biochemical pharmacology,
M Delaforge, and F Andre, and M Jaouen, and H Dolgos, and H Benech, and J M Gomis, and J P Noel, and F Cavelier, and J Verducci, and J L Aubagnac, and B Liebermann
March 1980, Biochemical pharmacology,
M Delaforge, and F Andre, and M Jaouen, and H Dolgos, and H Benech, and J M Gomis, and J P Noel, and F Cavelier, and J Verducci, and J L Aubagnac, and B Liebermann
November 1987, Biochemistry,
M Delaforge, and F Andre, and M Jaouen, and H Dolgos, and H Benech, and J M Gomis, and J P Noel, and F Cavelier, and J Verducci, and J L Aubagnac, and B Liebermann
December 1989, Biochemical pharmacology,
Copied contents to your clipboard!